MedTrace Logo

Variants of SARS-CoV-2 Causing COVID-19 in Africa

NCT05311891 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12600

Last updated 2022-05-27

No results posted yet for this study

Summary

The main objective of this research is to identify and characterize the different molecular variants of SARS-CoV-2, emerging and / or circulating in several countries of Sub-Saharan Africa (Burkina Faso, Côte d'Ivoire, Gabon, Mali, Chad and Republic of Congo) and determine their role in the evolution of the pandemic.

Conditions

Interventions

DIAGNOSTIC_TEST

RT PCR

Characterize the different molecular variants of SARS-CoV-2, determine the escape potential of the new variants from neutralization by monoclonal antibodies and currently available vaccines and characterization of the mRNAs expressed in infected persons

Sponsors & Collaborators

  • Institut de Recherche pour le Developpement

    collaborator OTHER_GOV

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2022-10-31
Completion
2022-10-31

Countries

  • Burkina Faso
  • Chad
  • Côte d’Ivoire
  • Gabon
  • Mali
  • Republic of the Congo

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05311891 on ClinicalTrials.gov